NDC 53002-4300
Furosemide 40 mg tablet
On the label: RPK Pharmaceuticals, Inc.. It's repackaged: RPK Pharmaceuticals, Inc. rebottles it from Leading Pharma, LLC's NDC 69315-117.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Leading Pharma, LLC | Fairfield, NJ, United States | Makes it | Problems found, fixed voluntarilyOct 21, 2024 · 13 inspections |
Repackaging site
- RPK Pharmaceuticals, Inc., Union City, California, United States · repackages it and relabels it
Recalls
- Mar 20, 2026 · Class II · Leading Pharma, LLC
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Lots: Lots# H03125, H03225, H03325, Exp Date: 2027/08
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Furosemide: every company that makes it
- Form
- tablet
- Strength
- 40 mg
- Approval
- ANDA ANDA077293
- On the market since
- Feb 1, 2006
- Package NDCs
53002-4300-053002-4300-3- Official label
- DailyMed (National Library of Medicine), updated Jun 7, 2023
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?